LAMBERTVILLE, N.J., Oct. 1 /PRNewswire/ -- Health Strategies Group, a leading provider of market intelligence to the pharmaceutical and biotechnology industries, has just launched Oncology Performance Edge, a new strategic research service that helps marketing and sales executives in the oncology field improve brand performance by understanding how best to invest their resources.
"The oncology market is significantly different from others, with unique challenges," said Denise Woltemath, senior consultant for specialty/bio at Health Strategies Group.
"It faces a rapidly changing selling environment, a professional audience with disparate needs, and distinct obstacles to measuring the value and effectiveness of sales representatives and support services. The goal of Oncology Performance Edge is to help companies successfully address these issues, stay ahead of emerging trends, and make optimal use of their resources, both now and in the future."
Oncology Performance Edge includes three offerings, plus access to Health Strategies Group oncology experts, who help clients apply the market intelligence to their businesses objectives. These offerings include:
Total Office Call - A guide to understanding the most effective methods and messages for communicating with all audiences who influence oncology brand performance, including nurses, reimbursement coordinators, office administrators, infusion center personnel, and staff at cancer treatment facilities. Total Office Call identifies which marketing and sales resources these decision-makers value most, their level of satisfaction with current offerings, and unmet needs or ineffectively deployed resources by the company.
"Total Office Call is about knowing all audiences who influence the prescribing of your oncology product, understanding what matters to each, and meeting each group's needs with relevant content and support," said Woltemath,.
Oncology Sales Opportunity Assessment - Evaluates four key factors (behaviors, knowledge, support and promotional resources) that increase a sales representative's value to oncologists. Reflecting the perspectives of specialists in five key areas - breast, hematologic, gastrointestinal/colorectal, lung, and prostate cancers - the data provide disease-specific insights.
"We know this framework is effective because we've validated it in eight specialty and biotech markets," Woltemath notes. "Companies with representatives who demonstrate specific behaviors and knowledge identified through our research have garnered significant increases in market share or volume."
Current and Future Selling Environment - Analyzes key trends and dynamics affecting the selling landscape for oncology products and helps direct sales strategies and resource allocation over the next one to two years. It examines the impact of a comprehensive range of influences, including treatment guidelines, specialty pharmacy management, changes in "buy and bill," and mandatory preferred product lists.
For additional information on Oncology Performance Edge, contact Karen Vandeven, director of marketing and communications for Health Strategies Group, at (609) 397-5282 or email@example.com.
About Health Strategies Group
Health Strategies Group has been providing market intelligence to pharmaceutical and biotechnology professionals since 1992, transforming research findings into practical insights and strategic recommendations to help organizations make the best business decisions. The company has long-standing relationships with 90 percent of the nation's leading pharmaceutical and biotechnology companies.
Health Strategies Group services include syndicated research reports in different practice areas, proprietary intelligence projects on request, and direct, continuous access to a team of research directors and practice leaders who are experienced veterans of the pharmaceutical industry and active thought leaders in their areas of expertise. The company also creates a custom webpage for each client that provides ready access to all pertinent publications and research summaries.
Organizations use Health Strategies Group to assess marketplace trends and future scenarios, support business planning, formulate successful segmentation strategies, guide the design of training curricula, educate colleagues, benchmark staff performance, and develop more profitable contracting strategies.
Health Strategies Group is headquartered in Lambertville, N.J., with regional offices in Redwood City, Carlsbad and Irvine, Calif. Visit the company's Web site
CONTACT: Julie Laitin (212) 286-2424 Cynthia Amorese (908) 665-8072 Email: firstname.lastname@example.org Email: email@example.com
SOURCE Health Strategies Group
|SOURCE Health Strategies Group|
Copyright©2009 PR Newswire.
All rights reserved